The FDA’s approval of a nasal mist flu vaccine for at-home use represents more than just a convenient alternative to the traditional flu shot — it marks a significant shift in healthcare delivery, moving toward a decentralized model where patients can self-administer care from the comfort of their own homes.
The FDA’s approval of a nasal mist flu vaccine for at-home use represents more than just a convenient alternative to the traditional flu shot — it marks a significant shift in healthcare delivery, moving toward a decentralized model where patients can self-administer care from the comfort of their own homes.
Diabetes is associated with significant long-term costs for both patients and health systems. Regular primary care visits aligned with American Diabetes Association guidelines could help mitigate those costs while generating near-term revenue for health systems. Digital interventions prompting primary care visits among unengaged patients could provide significant economic value back to the health system as well as individual patients, but only few economic models have been put forth to understand this value. Lirio’s model has been published in JMIR Formative.
COVID-19 affects everyone, but harmfully affects people with diabetes, which caused many to delay care during the pandemic. Learn about Lirio’s innovative Precision Nudging solution built to help diabetes patients resume care and remain digitally engaged in between appointments.
Lirio, whose Precision Nudging™ solution promotes health through AI-powered behavior change, today announced the launch of a new Precision Nudging™ solution to help people with diabetes receive recommended health care. The solution was co-developed with Bon Secours Mercy Health (BSMH), one of the 20 largest hospital systems in the United States, to close gaps in diabetes care and improve the health of the diabetes community it serves.
